Orthopedic Viscosupplementation is fastest growing segment fueling the growth of Viscosupplementation Market

 Viscosupplementation refers to intra-articular injection of hyaluronic acid (HA) or its derivatives into the knee joint intended to provide added lubrication and support to the joints. The injections are used to treat osteoarthritis of the knee which helps to decrease pain, increase mobility and provide protective cushioning to the joint.

The global Viscosupplementation Market is estimated to be valued at US$ 3,146.7 Mn or in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
One of the key trends in the viscosupplementation market is the development and launch of single-injection therapies. Unlike multi-injection therapies that require multiple injections over several weeks, single-injection viscosupplements are injected only once to provide sustained relief for about 6 months. This provides better patient compliance compared to multiple injections and also reduces the overall treatment cost. For instance, in 2020, Ferring Pharmaceuticals received FDA approval for its single-injection viscosupplement Qgel (beclomethasone dipropionate) for osteoarthritis pain in the knee.
Segment Analysis
The global viscosupplementation market is segmented on the basis of product, injection, application and end user. Based on product, the three-injection viscosupplementation segment holds the largest market share due to minimal invasiveness and long-term relief from osteoarthritis related pain. On the basis of injection, the three injections segment holds the maximum share as it offers viscosupplementation in knee joints for 3 to 6 months. By application, the knee osteoarthritis segment dominates as knee is the most commonly affected joint. Hospitals segments holds the largest share in end user segment due to availability of skilled professionals and advanced treatment facilities.

Key Takeaways

The global viscosupplementation market is expected to witness high growth, exhibiting CAGR of 8.2% over the forecast period, due to increasing geriatric population suffering from osteoarthritis.

Regional analysis - North America dominates the global viscosupplementation market owing to rising prevalence of osteoarthritis in the region. Europe accounts for the second largest market share due to increasing healthcare expenditure and advanced medical facilities. Asia Pacific exhibits the fastest growth due to rising healthcare standards in countries like China and India.

Key players - Key players operating in the viscosupplementation market are Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, and Johnson & Johnson. Anika Therapeutics dominates the market owing to its extensive portfolio of hyaluronic acid-based products for osteoarthritis treatment.

Comments

Post a Comment

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Image
The pituitary cancer market comprises of medical treatment options for patients diagnosed with pituitary cancer. Pituitary cancers are rare tumors that start in the pituitary gland which is a pea-sized gland located at the base of the brain.  The global Pituitary Cancer Market is estimated to be valued at US$ 380.7 Mn in 2023 and is expected to exhibit a CAGR of 9.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.    Market key trends: One of the key trends fueling the growth of the pituitary cancer market is rising preference of targeted drug therapy over conventional chemotherapy. Targeted drug therapies mainly include somatostatin analogs and dopamine agonists which directly act on cancer cells and have less side effects compared to chemotherapy. These targeted drugs are effective in controlling symptoms and slowing tumor growth in patients with hormone secreting pituitary adenomas and carcinomas. The targe...
Read more

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Image
  Hospital beds play a crucial role in patient care, providing comfort, safety, and functionality for individuals requiring medical attention. Over the years, advancements in technology and design have revolutionized hospital beds, leading to improved patient outcomes and caregiver efficiency. From basic adjustable beds to sophisticated models equipped with cutting-edge features, the evolution of hospital beds has transformed the healthcare landscape. Evolution of Hospital Beds: Historically, hospital beds were simple in design, primarily consisting of a metal frame with adjustable height and manual controls. However, as medical practices advanced and patient needs became more complex, the demand for more versatile and ergonomic hospital beds grew. In recent decades, significant strides have been made in the development of hospital bed technology. Modern hospital beds are designed with a focus on patient comfort, safety, and mobility. Features such as electronic controls, motorize...
Read more

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management

Image
  Dry eye disease, also known as keratoconjunctivitis sicca, is a multifactorial disease of the ocular surface characterized by lack of sufficient moisture and tear film instability. Common symptoms of dry eye include stingy or burning sensation in eyes and blurred vision.   Market Dynamics : The Dry Eye Disease Market is witnessing high growth owing to rising awareness about disease management and increasing number of people experiencing symptoms of dry eyes. According to the report, increasing usage of electronic devices and prolonged screen time is a major driver fueling the demand for dry eye treatments. Additionally, growing geriatric population worldwide who are more prone to dry eyes is also contributing to the market growth. Availability of various treatment options along with new product launches is further expected to boost the market during forecast period.   Increasing Prevalence of Dry Eye Disease is Driving Market Growth   One of the major market drive...
Read more